Sophie Vermond is a Scientist at Charles River Laboratories in Leiden, the Netherlands. Her research focuses on efficacy and toxicity testing of novel drug therapies in human primary cell-based models. Her main focus is assay development for T cell therapy safety studies. Furthermore, she is head of the flow cytometry group.
Early Discovery Scientist, Immunology, Immuno-oncology and Cell Therapy